{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:54:24Z","timestamp":1770468864732,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.autrev.2024.103656","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T14:58:12Z","timestamp":1728140292000},"page":"103656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of non-immunosuppressive medical therapy on disease progression and complications of Takayasu arteritis: A narrative review"],"prefix":"10.1016","volume":"23","author":[{"given":"Riccardo","family":"Terribili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Conticini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Grazzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Frediani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2024.103656_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2023.101845","article-title":"Classification and epidemiology of vasculitis: emerging concepts","volume":"37","author":"Ecclestone","year":"2023","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"7\u20138","key":"10.1016\/j.autrev.2024.103656_bb0010","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.lpm.2017.05.034","article-title":"Epidemiology of Takayasu arteritis","volume":"46","author":"Onen","year":"2017","journal-title":"Presse Med."},{"key":"10.1016\/j.autrev.2024.103656_bb0015","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0889-857X(21)00484-1","article-title":"Takayasu\u2019s arteritis","author":"Kerr","year":"1995","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.autrev.2024.103656_bb0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10238-020-00668-7","article-title":"Takayasu arteritis: a cohort of Italian patients and recent pathogenetic and therapeutic advances","volume":"21","author":"Dammacco","year":"2021","journal-title":"Clin. Exp. Med."},{"issue":"9234","key":"10.1016\/j.autrev.2024.103656_bb0025","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(00)02701-X","article-title":"Takayasu's arteritis","volume":"356","author":"Numano","year":"2000","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.autrev.2024.103656_bb0030","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.21037\/jtd-20-267","article-title":"A study on the risk factors of coronary artery disease in patients with Takayasu arteritis","volume":"12","author":"Wang","year":"2020","journal-title":"J Thorac Dis"},{"issue":"8","key":"10.1016\/j.autrev.2024.103656_bb0035","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/art.41774","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis","volume":"73","author":"Maz","year":"2021","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2024.103656_bb0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.autrev.2024.103656_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93416-0","article-title":"Prevalence of cardiovascular risk factors, the use of statins and of aspirin in Takayasu arteritis","volume":"11","author":"Laurent","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.autrev.2024.103656_bb0050","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1253\/circj.CJ-09-0905","article-title":"Antiplatelet therapy for the prevention of arterial ischemic events in Takayasu arteritis","volume":"74","author":"de Souza","year":"2010","journal-title":"Circ. J."},{"issue":"1","key":"10.1016\/j.autrev.2024.103656_bb0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijcard.2015.04.070","article-title":"Two young women with severe coronary arterial ostial narrowing: a potential subtype of Takayasu arteritis","volume":"189","author":"Yang","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.autrev.2024.103656_bb0060","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0741-5214(98)70332-5","article-title":"Successful delayed bilateral renal revascularization during active phase of Takayasu\u2019s arteritis","volume":"27","author":"Dardik","year":"1998","journal-title":"J. Vasc. Surg."},{"issue":"1","key":"10.1016\/j.autrev.2024.103656_bb0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF00852840","article-title":"Management of severe hypertension in childhood Takayasu\u2019s arteritis","volume":"5","author":"Milner","year":"1991","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.autrev.2024.103656_bb0070","first-page":"58","article-title":"Captopril in the treatment of renovascular hypertension secondary to Takayasu\u2019s arteritis. A case report","author":"Huddle","year":"1986","journal-title":"S. Afr. Med. J."},{"issue":"1","key":"10.1016\/j.autrev.2024.103656_bb0075","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archinte.1984.00350130107020","article-title":"Clinical use of captopril in Takayasu's disease","volume":"144","author":"Grossman","year":"1984","journal-title":"Arch. Intern. Med."},{"issue":"7","key":"10.1016\/j.autrev.2024.103656_bb0080","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/10641963.2017.1299747","article-title":"Treatment of severe hypertension in a 14-year-old child: successful blood pressure control with additive administration of captopril, an angiotensin-converting enzyme inhibitor, in a patient with bilateral renovascular hypertension","volume":"39","author":"Zhang","year":"2017","journal-title":"Clin. Exp. Hypertens."},{"issue":"1","key":"10.1016\/j.autrev.2024.103656_bb0085","first-page":"69","article-title":"Enalapril and losartan augment endogenous nitric oxide release in Takayasu\u2019s arteritis","volume":"51","author":"Marsen","year":"2000","journal-title":"doi:10.1177\/000331970005100111"},{"key":"10.1016\/j.autrev.2024.103656_bb0090","first-page":"325","article-title":"Usefulness of beta blocker therapy in patients with Takayasu arteritis and moderate or severe aortic regurgitation","author":"Moncada","year":"2000","journal-title":"Jpn. Heart J."},{"key":"10.1016\/j.autrev.2024.103656_bb0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijcard.2019.02.046","article-title":"Statins reduce relapse rate in Takayasu arteritis","volume":"287","author":"Kwon","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.autrev.2024.103656_bb0100","series-title":"Novel Th17 Lymphocyte Populations, Th17.1 and PD1+Th17, are Increased in Takayasu Arteritis, and Both Th17 and Th17.1 Sub-Populations Associate with Active Disease","author":"Singh","year":"2022"},{"issue":"10","key":"10.1016\/j.autrev.2024.103656_bb0105","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1007\/s10067-017-3947-4","article-title":"The presentation and management of hypertension in a large cohort of Takayasu arteritis","volume":"37","author":"Qi","year":"2018","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.autrev.2024.103656_bb0110","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/hrt.36.1.114","article-title":"Reversal of renovascular hypertension caused by nonspecific aortitis after corticosteroid therapy","volume":"36","author":"Kulkarni","year":"1974","journal-title":"Br. Heart J."},{"key":"10.1016\/j.autrev.2024.103656_bb0115","series-title":"Takayasu arteritis as a cause of arterial hypertension. Case report and literature review","author":"Sadurska","year":"2024"},{"issue":"1","key":"10.1016\/j.autrev.2024.103656_bb0120","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/art.20922","article-title":"Takayasu's arteritis: a study of 104 Italian patients","volume":"53","author":"Vanoli","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.autrev.2024.103656_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2023.101826","article-title":"Management of Takayasu arteritis","volume":"37","author":"Misra","year":"2023","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.autrev.2024.103656_bb0130","first-page":"69","article-title":"Enalapril and losartan augment endogenous nitric oxide release in Takayasu\u2019s arteritis","volume":"51","author":"Marsen","year":"2000","journal-title":"doi:10.1177\/000331970005100111"},{"key":"10.1016\/j.autrev.2024.103656_bb0135","author":"Subramanyan"},{"issue":"6","key":"10.1016\/j.autrev.2024.103656_bb0140","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0002-9149(84)90420-X","article-title":"Clinical features and course of aortitis syndrome in japanese women older than 40 years","volume":"53","author":"Morooka","year":"1984","journal-title":"Am. J. Cardiol."},{"issue":"5","key":"10.1016\/j.autrev.2024.103656_bb0145","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1253\/circj.70.600","article-title":"P-selectin expression, but not GPIIb\/IIIa activation, is enhanced in the inflammatory stage of Takayasu's arteritis","volume":"70","author":"Kasuya","year":"2006","journal-title":"Circ. J."},{"issue":"1","key":"10.1016\/j.autrev.2024.103656_bb0150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1253\/jcj.46.16","article-title":"Changes in the plasma levels of thromboxane B2 and cyclic nucleotides in patients with Takayasu disease","volume":"46","author":"Numano","year":"1982","journal-title":"Jpn. Circ. J."},{"issue":"5","key":"10.1016\/j.autrev.2024.103656_bb0155","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1055\/s-0038-1650353","article-title":"Hypercoagulable state in patients with Takayasu's arteritis","volume":"75","author":"Akazawa","year":"1996","journal-title":"Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.autrev.2024.103656_bb0160","article-title":"Takayasu arteritis and atherosclerosis: illustrating the consequences of endothelial damage","volume":"28","author":"Filer","year":"2001","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.autrev.2024.103656_bb0165","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/ard.2005.047498","article-title":"Atherosclerosis in Takayasu arteritis","volume":"65","author":"Seyahi","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.autrev.2024.103656_bb0170","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/eurheartj\/ehu403","article-title":"Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions","volume":"36","author":"Mason","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.autrev.2024.103656_bb0175","series-title":"Myeloperoxidase, modified lipoproteins, and atherogenesis","author":"Nicholls","year":"2009"},{"issue":"2","key":"10.1016\/j.autrev.2024.103656_bb0180","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0049-0172(97)80010-8","article-title":"Specificity, pathogenecity, and clinical value of antiendothelial cell antibodies","volume":"27","author":"Belizna","year":"1997","journal-title":"Semin. Arthritis Rheum."},{"issue":"3 SUPPL","key":"10.1016\/j.autrev.2024.103656_bb0185","first-page":"49","article-title":"The role of the endothelium in systemic small vessel vasculitis","volume":"26","author":"Little","year":"2008","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.autrev.2024.103656_bb0190","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/art.1780400322","article-title":"Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-\u03b22-glycoprotein I antibodies react in vitro with endothelial cells through adherent \u03b22-glycoprotein I and induce endothelial activation","volume":"40","author":"Del Papa","year":"1997","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.autrev.2024.103656_bb0195","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/art.21976","article-title":"Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"54","author":"McMahon","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.autrev.2024.103656_bb0200","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0889-8529(05)70033-5","article-title":"DRUGS CAUSING DYSLIPOPROTEINEMIA","volume":"27","author":"Donahoo","year":"1998","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"issue":"10","key":"10.1016\/j.autrev.2024.103656_bb0205","first-page":"695","article-title":"Antiaggregative aspirin dosage at the affected Vessel Wall","volume":"37","author":"Numano","year":"1986","journal-title":"doi:10.1177\/000331978603701001"},{"issue":"9","key":"10.1016\/j.autrev.2024.103656_bb0210","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1185\/030079907X226104","article-title":"Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol","volume":"23","author":"Bergheanu","year":"2007","journal-title":"Curr. Med. Res. Opin."},{"issue":"3","key":"10.1016\/j.autrev.2024.103656_bb0215","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.semarthrit.2007.03.002","article-title":"PON1, a new biomarker of cardiovascular disease, is low in patients with systemic Vasculitis","volume":"37","author":"Qu\u00e9m\u00e9neur","year":"2007","journal-title":"Semin. Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.autrev.2024.103656_bb0220","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1253\/circj.CJ-08-0582","article-title":"Altered flow-mediated vasodilatation, low Paraoxonase-1 activity, and abnormal high-density lipoprotein subclass distribution in Takayasu's arteritis","volume":"73","author":"Espinola-Zavaleta","year":"2009","journal-title":"Circ. J."},{"issue":"3","key":"10.1016\/j.autrev.2024.103656_bb0225","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/08916934.2015.1027818","article-title":"The role of statins in inflammatory vasculitides","volume":"48","author":"Tremoulet","year":"2015","journal-title":"Autoimmunity"},{"issue":"6911","key":"10.1016\/j.autrev.2024.103656_bb0230","first-page":"78","article-title":"The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease","volume":"420","author":"Youssef","year":"2002","journal-title":"Nature 2002 420:6911"},{"issue":"4","key":"10.1016\/j.autrev.2024.103656_bb0235","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaut.2005.06.005","article-title":"Effects of atorvastatin on the Th1\/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats","volume":"25","author":"Liu","year":"2005","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.autrev.2024.103656_bb0240","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/ar3814","article-title":"Statins accelerate the onset of collagen type II-induced arthritis in mice","volume":"14","author":"Vandebriel","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.autrev.2024.103656_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000336","article-title":"Persistence with statins and onset of rheumatoid arthritis: a population-based cohort study","volume":"7","author":"Chodick","year":"2010","journal-title":"PLoS Med."},{"issue":"7","key":"10.1016\/j.autrev.2024.103656_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041289","article-title":"Statin-associated polymyalgia Rheumatica. An analysis using WHO global individual case safety database: a case\/non-case approach","volume":"7","author":"de Jong","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.autrev.2024.103656_bb0255","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/ard.2011.155622","article-title":"Use of statins is associated with an increased risk of rheumatoid arthritis","volume":"71","author":"De Jong","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.autrev.2024.103656_bb0260","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.semarthrit.2011.06.002","article-title":"Association between statin use and lupus-like syndrome using spontaneous reports","volume":"41","author":"de Jong","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.autrev.2024.103656_bb0265","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.semarthrit.2017.11.001","article-title":"Ischemic complications in Takayasu's arteritis: a meta-analysis","volume":"47","author":"Kim","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.autrev.2024.103656_bb0270","doi-asserted-by":"crossref","first-page":"171","DOI":"10.31138\/mjr.30.3.171","article-title":"Mediterranean Journal of Rheumatology association between Takayasu arteritis and ischemic heart disease: a cohort study","volume":"30","author":"Amital","year":"2019","journal-title":"Mediterr J Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2024.103656_bb0275","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1161\/CIRCULATIONAHA.116.027094","article-title":"Long-term outcomes and prognostic factors of complications in Takayasu arteritis","volume":"136","author":"Comarmond","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2024.103656_bb0280","doi-asserted-by":"crossref","unstructured":"S. Yang et al., \u201cCoronary artery calcification in Takayasu's arteritis: clinical characteristics and risk factors,\u201d Clin. Exp. Rheumatol., Aug. 2023, doi: 10.55563\/clinexprheumatol\/ypq2lj.","DOI":"10.55563\/clinexprheumatol\/ypq2lj"},{"key":"10.1016\/j.autrev.2024.103656_bb0285","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jcmg.2017.10.012","article-title":"Coronary artery calcification and its progression what does it really mean?","volume":"11","author":"Mori","year":"2018","journal-title":"J. Am. Coll. Cardiol. Img."},{"issue":"4","key":"10.1016\/j.autrev.2024.103656_bb0290","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.120.315737","article-title":"Statin effects on vascular calcification: microarchitectural changes in aortic calcium deposits in aged hyperlipidemic mice","volume":"41","author":"Xian","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.autrev.2024.103656_bb0295","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1136\/annrheumdis-2015-207872","article-title":"Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis","volume":"75","author":"Gabay","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.autrev.2024.103656_bb0300","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann. Rheum. Dis."}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224001472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224001472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T03:12:38Z","timestamp":1732677158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997224001472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":60,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1568997224001472"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103656","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of non-immunosuppressive medical therapy on disease progression and complications of Takayasu arteritis: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103656","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103656"}}